JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HAESE, W. H.
Right arrow Articles by BUEDING, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HAESE, W. H.
Right arrow Articles by BUEDING, E.
Journal of Pharmacology And Experimental Therapeutics, Vol. 186, Issue 3, 430-440, 1973
Copyright © 1973 by American Society for Pharmacology and Experimental Therapeutics


HYCANTHONE-INDUCED HEPATIC CHANGES IN MICE INFECTED WITH SCHISTOSOMA MANSONI

WOLFGANG H. HAESE 1, DUANE L. SMITH 1, and ERNEST BUEDING 1

1 Departments of Pathology and of Pharmacology and Experimental Therapeutics, School of Medicine; Department of Pathobiology, School of Hygiene and Public Health, The Johns hopkins University, Baltimore, Maryland

Fifty-four to 104 weeks after infection of female mice with cercariae of Schistosoma mansoni, hepatic hyperplasia was observed in 29% of the animals. Cessation of egg production and elimination of the worms, brought about by the administration of the schistosomicidal drug SQ 18,506 55 days after infection, resulted in a lower incidence of hepatic hyperplasias. By contrast, administration of a single dose of hycanthone, another antischistosomal drug, produced a significant increase in the incidence of hepatic hyperplasia. Furthermore, in contrast to SQ 18,506-treated controls, the appearance of hepatocellular carcinomas was observed in hycanthone-treated infected mice, even after the adult worms had been killed and the deposition of eggs had been eliminated. In uninfected mice administration of a single dose of hycanthone produced neither hepatic hyperplasia nor hepatomas. It is concluded that the hepatic hyperplasia, induced by the deposition of schistosome eggs in the liver and enhanced by hycanthone, is a predisposing factor for a hepatocarcinogenic effect of this drug.

Submitted on January 11, 1973
Accepted on May 29, 1973







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1973 by the American Society for Pharmacology and Experimental Therapeutics.